The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate?

Acta Psychiatr Scand. 2019 Oct;140(4):386-387. doi: 10.1111/acps.13085.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Humans
  • Observational Studies as Topic
  • Placebos / administration & dosage*
  • Schizophrenia / drug therapy*
  • Schizophrenia / prevention & control
  • Secondary Prevention / ethics*
  • Secondary Prevention / methods*
  • Substance Withdrawal Syndrome / epidemiology

Substances

  • Antipsychotic Agents
  • Placebos